Mruk-Med Sp. z o.o
Rzeszów 35-234
1 studies enrolling now · 1 studies all time
What they study most
Advanced Breast Cancer, Breast Cancer, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Metastatic Breast Cancer, PIK3CA Mutation
Rzeszów 35-234
1 studies enrolling now · 1 studies all time
Advanced Breast Cancer, Breast Cancer, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Metastatic Breast Cancer, PIK3CA Mutation